ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Advocacy
  • Anal cancer
  • Artificial intelligence (AI)
  • Bladder cancer
  • Brain cancer
  • Breast cancer
  • Colorectal cancer
  • ComboMATCH
  • Esophagus cancer
  • Gallbladder cancer
  • Head and neck cancer
  • Health equity
  • Immunotherapy
  • In memory
  • Kidney cancer
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Mammography
  • Melanoma
  • Myelodysplastic syndrome
  • Myeloma
  • NCI-MATCH
  • Older adults
  • Pancreatic cancer
  • Pancreatic cysts
  • Patient education
  • Patient navigation
  • Patient-reported outcomes
  • Penis cancer
  • Personalized treatment
  • Policy
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Real-world data/evidence
  • Research results
  • Sarcoma
  • Screening for cancer
  • Side effects
  • Survivorship
  • Targeted therapy
  • Upper tract urothelial cancer
  • Young adults
July 19, 2023
July 19, 2023
Categories
  • Ongoing Trials

A closer look at ECOG-ACRIN’s men’s cancer trials

These trials are exploring new treatment approaches for adults with prostate or penile cancer
Do you like it?
0 Read more
March 23, 2023
March 23, 2023
Categories
  • Ongoing Trials

Video: Advocates discuss the EA2185 research study for patients with pancreatic cysts

Watch cancer research advocates Lisa Beckendorf and Steven Merlin discuss the EA2185 study for patients with pancreatic cysts
Do you like it?
0 Read more
March 23, 2023
Doctor talking with older male patient
March 23, 2023
Categories
  • Ongoing Trials

Ongoing Trials: A closer look at ECOG-ACRIN’s myeloma studies

These two trials are exploring new treatment approaches for adults with multiple myeloma
Do you like it?
0 Read more
January 5, 2023
January 5, 2023
Categories
  • Ongoing Trials

Ongoing Trial: The INSPIRE research study is testing a new treatment approach for patients with advanced bladder cancer

This trial is evaluating the effect of adding immune system therapy to the usual treatment (chemotherapy and radiation)
Do you like it?
0 Read more
Prev page
1234567
Next page

Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc